文献速递主动脉疾病

孤立性腹主动脉夹层的发病率与自然病史:1995至2015年基于人群的评估

Incidence and natural history of isolated abdominal aortic dissection: A population-based assessment from 1995 to 2015.
PubMed 文献 · J Vasc Surg · 2020-08-27

该研究利用罗切斯特流行病学项目识别1995至2015年Olmsted县居民中主动脉夹层、壁内血肿或穿透性溃疡患者,经影像复核确诊14例孤立性腹主动脉夹层。初始治疗以药物为主,主动脉年增长率为0.09 cm/年,无主动脉相关死亡,总生存率与人群对照相似,但心力衰竭和心脏相关死亡常见。

要点

  • 孤立性腹主动脉夹层罕见,多数无症状,初始治疗以药物为主。
  • 主动脉扩张缓慢,年增长率0.09 cm/年,主动脉干预率低,无主动脉相关死亡。
  • 心力衰竭和心脏相关死亡常见,需密切心血管管理。

核心结论

  • 孤立性腹主动脉夹层罕见,无症状患者初始治疗为药物,主动脉增长缓慢,无主动脉相关死亡,总死亡率与人群对照相似。
  • 心力衰竭和心脏相关死亡常见,提示该人群需要密切的心血管管理。

研究设计与样本

  • 基于罗切斯特流行病学项目的人群评估,纳入1995至2015年Olmsted县居民中诊断为主动脉夹层、壁内血肿或穿透性溃疡的患者。
  • 经影像复核确诊14例孤立性腹主动脉夹层患者(10例男性,占71%,平均年龄71岁),并与年龄和性别匹配的人群对照按3:1比较生存。

主要发现

  • 14例患者中3例(21%)有症状(腹痛、背痛、高血压),无灌注不良或破裂。
  • 8例(57%)存在既往主动脉扩张,1例(7%)有马凡综合征,2例(14%)为医源性孤立性腹主动脉夹层。
  • 初始治疗13例为药物,1例为EVAR;中位临床和影像随访6.7年(范围0-17年)。
  • 8例发生腹主动脉瘤(6例在诊断时,1例在2.9年后,1例在5.2年后),整个队列平均增长0.9±0.4 cm,平均增长率0.09 cm/年。
  • 2例后续干预(1例因严重主动脉瓣狭窄伴跛行行肾下主动脉支架置入,1例因主动脉尺寸增加行开放修复),1例需再次干预(EVAR分支血栓行溶栓和支架置入)。

临床怎么用

  • 无症状孤立性腹主动脉夹层患者可首选药物治疗。
  • 需定期影像随访监测主动脉扩张和动脉瘤形成。
  • 应重视心力衰竭等心血管并发症的筛查和管理。

局限性

  • 样本量小(14例),可能限制统计效能和普遍性。
  • 为回顾性人群研究,存在选择和信息偏倚可能。
  • 随访时间范围宽(0-17年),部分患者随访可能不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Isolated abdominal dissection (IAD) is an uncommon clinical problem that is less well-understood than thoracic aortic dissection (AD). We performed a population-based assessment of the incidence, natural history, and treatment outcomes of IAD to better characterize this disease. METHODS: We used the Rochester Epidemiology Project to identify all Olmsted County, MN residents with a diagnosis of AD, intramural hematoma or penetrating ulcer (1995-2015). Diagnostic imaging of all patients was reviewed to confirm the diagnosis of IAD for inclusion. Presentation, treatment, and outcomes were reviewed. Survival of IAD patients was compared to age- and sex-matched population controls 3:1. RESULTS: Of 133 residents with aortic syndrome (AD, intramural hematoma, or penetrating ulcer), 23 were initially diagnosed with IAD. Nine were reclassified as having a penetrating aortic ulcer and were excluded, leaving 14 patients for review (10 male [71%]; mean age, 71 years). Three patients (21%) were symptomatic (abdominal pain, back pain, hypertension) and none had malperfusion or rupture. Prior aortic dilatation was present in eight patients (57%) and Marfan syndrome in one (7%). Two patients (14%) had iatrogenic IAD. Initial management was medical in 13 and endovascular aneurysm repair in one (symptomatic subacute, infrarenal dissection with small aneurysm). The median clinical and imaging follow-up was 6.7 years (range, 0-17 years). An abdominal aortic aneurysm occurred in eight (six at the time of IAD diagnosis, one at 2.9 years, and one at 5.2 years after diagnosis). The average growth in the entire cohort was 0.9 ± 0.4 cm, which translated to an average growth rate of 0.09 cm/year. Subsequent intervention was performed in two patients; for severe aortic stenosis with claudication in one (infrarenal aortic stenting) and increasing aortic size in one (open repair). One patient required reintervention (thrombolysis and stenting for endovascular aneurysm repair limb thrombosis). Survival for IAD at 1, 3, and 5 years was 93%, 85%, and 76%, respectively, compared with population controls at 98%, 85%, and 71%, respectively (long rank P = .38). Mortality was due to cardiovascular causes in three patients (21%) and no deaths were aortic related. Major adverse cardiac events occurred in five patients (36%) owing to heart failure. CONCLUSIONS: IAD is rare. The initial management for asymptomatic patients is medical. The aortic growth rate is slow, with no aortic-related mortality and a low rate of aortic intervention. The overall mortality is similar to population controls. Heart failure and cardiac-related death are prevalent, suggesting that close cardiovascular care is needed in this patient population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sen I, D'Oria M, Weiss S, et al. Incidence and natural history of isolated abdominal aortic dissection: A population-based assessment from 1995 to 2015. J Vasc Surg. 2020. PMID: 32861864. doi:10.1016/j.jvs.2020.07.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。